Oculus Innovative Sciences (NASDAQ: OCLS) has exploded 29% or $.52 to settle at $2.36 a share with an increased volume of 3,000,812 shares. The company announced today that it has received the new FDA 510 clearance for its uniquely formulated microcyn-based Epicyn Hydrogel product. Oculus Innovative has a market capitalization of $63 million.
Oculus Innovative Sciences, Inc. develops, manufactures and markets a family of tissue care products that cure infections, and through a separate mechanism of action, enhance healing while reducing the need for antibiotics. The Company's platform technology, called Microcyn, is a solution of electrically charged oxychlorine small molecules designed to treat a range of organisms that cause disease (pathogens).
LRAD Corporation (NASDAQ: LRAD) has gained 5.47% or $.11 to settle at $2.12 with the light volume of 93,330 shares traded by midday. The company has a market capitalization of $65 million and an average volume of 155,033 shares. It has a 52-week range of $.71 to $3.10 and a days range of $2.05 to $2.14. Stock has shown an increased activity after the company has announced that it will receive $4.3 million to a warrant exercise priced at $2.67 per share.
LRAD Corporation, formerly American Technology Corporation is engaged in the design, development and commercialization of directed sound technologies and products. The Company develops and delivers directed acoustic products that beam, focus and control sound over short and long distances.
Crosshair Exp. & Mining (AMEX: CXZ) has gained 1.21% or three cents to settle at $2.50 a share with a surging volume of 1.9 million shares that is at least twice the average of 781,463 shares. Company announced today an update on the central mineral belts joint venture uranium project in central Canada. During the summers of 2009 and 2010, geological mapping, sampling programs and prospecting were conducted to evaluate the priority targets that was generated from airborne geophysical and ground geochemical surveys. Several new uranium showings were discovered and these will be followed up during the 2011 summer drilling in trenching program.
Crosshair Exploration & Mining Corp. is a mineral exploration company engaged in the acquisition and exploration of mineral properties (primarily uranium, base and precious metals). The Company is focused on the exploration and evaluation of various mineral deposits in North America.
CytRx Corporation (NASDAQ: CYTR) has gained 4.33% or three cents a share to settle at $.84 a share with a moderate volume of 459,352 and in average volume of 520,084. The market capitalization of the company is $91.7 million with a 52 week trading range of $.62 to $1.45 a share. The company announced that the results from a series of preclinical studies show that Bafetinib may be useful in preventing bone loss in cancer patients that are at high risk for this event.
CytRx Corporation is a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, specializing in oncology. Its drug development pipeline includes clinical development of three product candidates for cancer indications, including three planned Phase II clinical trials for INNO-206 as a treatment for pancreatic cancer, gastric (stomach) cancer and soft tissue sarcomas.
Richmont Mines Inc. (AMEX: RIC) has gained 5.68% or $.26 to settle at $4.84 with an increased volume of 206,839 shares, which is twice the average of 104,775 shares traded. The company has a market capitalization of $150 million. In a report CEO of the company Martin Rivard, has stated that he's pleased with the results obtained from the 2010 drilling program as he confirmed that the existence of a strong mineralized system between the -200 and -800 m elevations that remains open at depth in several areas over lateral extension of 2 km. He also stated that the drills are continuously working at full capacity at the same Wasamac Properties.
Richmont Mines Inc. (Richmont Mines) is engaged in the acquisition, exploration, operation, financing and development of mineral properties. As of December 31, 2009, the Company operated two gold mines, which included Beaufor Mine in Quebec and Island Gold Mine in Ontario. All the mining titles of the Beaufor property are jointly held by Richmont Mines (50%), which is the operator of the property and by Louvem Mines Inc. (50%).
OTCPicks.com is not a
registered investment advisers or broker/dealer. OTCPicks.com makes no
recommendation that the purchase of securities of companies profiled in this
website is suitable or advisable for any person or that an investment such
securities will be profitable. In general, given the nature of the companies
profiled and the lack of an active trading market their securities, investing
in such securities is highly speculative and carries a high degree of risk.
Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any stocks listed in this stock news report
